Furthermore, GPR68 didn’t show any prognostic potential in BC patients unless they were classified according to their molecular subtypes, which is similar to the findings reported by Zhang et al. where the high GPR68 expression group did not have different survival rates (25). This evidence concerns the gene GPR68 and breast cancer.